Celltrion Investor
Celltrion engaged in the research, development, and manufacture of therapeutic proteins.
Technology:
Others
Industry:
Longevity Industry 2022
Headquarters:
Incheon, Inch'on-jikhalsi, South Korea
Founded Date:
2002
Employees Number:
501-1000
Funding Status:
IPO
Investor Type:
For Profit
Register and Claim Ownership